These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. High-level microsatellite instability in appendiceal carcinomas. Taggart MW; Galbincea J; Mansfield PF; Fournier KF; Royal RE; Overman MJ; Rashid A; Abraham SC Am J Surg Pathol; 2013 Aug; 37(8):1192-200. PubMed ID: 23648460 [TBL] [Abstract][Full Text] [Related]
45. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997 [No Abstract] [Full Text] [Related]
46. Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. Wyvekens N; Tsai HK; Sholl LM; Tucci J; Giannico GA; Gordetsky JB; Hirsch MS; Barletta JA; Acosta AM Histopathology; 2022 Jun; 80(7):1050-1060. PubMed ID: 35395112 [TBL] [Abstract][Full Text] [Related]
47. An exploration of gastric cancer with heterogeneous mismatch repair status. Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896 [TBL] [Abstract][Full Text] [Related]
48. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. Bessa X; Alenda C; Paya A; Álvarez C; Iglesias M; Seoane A; Dedeu JM; Abulí A; Ilzarbe L; Navarro G; Pellise M; Balaguer F; Castellvi-Bel S; Llor X; Castells A; Jover R; Andreu M J Clin Oncol; 2011 Sep; 29(25):3374-80. PubMed ID: 21788563 [TBL] [Abstract][Full Text] [Related]
49. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers. Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216 [TBL] [Abstract][Full Text] [Related]
50. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860 [TBL] [Abstract][Full Text] [Related]
51. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
52. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710 [TBL] [Abstract][Full Text] [Related]
53. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984 [TBL] [Abstract][Full Text] [Related]
54. Germline mutational profile of Chinese patients under 70 years old with colorectal cancer. Jiang TJ; Wang F; Wang YN; Hu JJ; Ding PR; Lin JZ; Pan ZZ; Chen G; Shao JY; Xu RH; Zhao Q; Wang F Cancer Commun (Lond); 2020 Nov; 40(11):620-632. PubMed ID: 32914570 [TBL] [Abstract][Full Text] [Related]
55. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH; Wu HW; Wang J; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653 [No Abstract] [Full Text] [Related]
56. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis. Sameer AS; Nissar S; Fatima K Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649 [TBL] [Abstract][Full Text] [Related]
57. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Kastrinos F; Steyerberg EW; Mercado R; Balmaña J; Holter S; Gallinger S; Siegmund KD; Church JM; Jenkins MA; Lindor NM; Thibodeau SN; Burbidge LA; Wenstrup RJ; Syngal S Gastroenterology; 2011 Jan; 140(1):73-81. PubMed ID: 20727894 [TBL] [Abstract][Full Text] [Related]
58. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900 [No Abstract] [Full Text] [Related]
59. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers. Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J; Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137 [TBL] [Abstract][Full Text] [Related]
60. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]